RSV Roundtable: Nirsevimab's impact

EP: 1.RSV Roundtable: What clinicians are witnessing in terms of RSV incidence

EP: 2.RSV Roundtable: Disease education, vaccine hesitancy, and awareness

Now Viewing

EP: 3.RSV Roundtable: Nirsevimab's impact

EP: 4.RSV Roundtable: Addressing the senior population

EP: 5.The clinical takeaways of the RSV immunizations

EP: 6.RSV this year: Clinician insights and urgent vaccination strategies

Welcome to the third episode of our 5-episode series; respiratory syncytial virus (RSV) Roundtable, a collaborative project from Contemporary Pediatrics, Contagion, and Contemporary OB/GYN.

This series discusses several aspects of RSV including incidence rates, vaccines, and immunizations.

In this episode, our panel highlights what type of impact nirsevimab (Beyfortus; Sanofi, AstraZeneca) has made this RSV season. In this discussion, the monoclonal antibody's availability and rollout process is also in the spotlight amid a plan to roll out some 230,000 additional doses in January 2024.

Our panel of clinicians includes:

• Robert H. Hopkins Jr., MD: medical director, National Foundation for Infectious Diseases; professor of Internal Medicine and Pediatrics; chief, Division of General Internal Medicine, University of Arkansas for Medical Sciences
• William Muller, MD, PhD: attending physician, Infectious Diseases; Ted Emerson Miller research scholar; professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine; scientific director, Clinical and Community Trials, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children’s Hospital
• Sallie Permar, MD, PhD: Nancy C. Paduano professor and chair, Department of Pediatrics, Weill Cornell Medicine; pediatrician-in-chief, New York-Presbyterian/Weill Cornell Medical Center
• Laura Riley, MD: chair, Department of Obstetrics and Gynecology, Weill Cornell Medicine; obstetrician and gynecologist-in-chief, New York-Presbyterian/Weill Cornell Medical Center
• Neil Silverman, MD: professor, obstetrics and gynecology, David Geffen School of Medicine, UCLA; director, Maternal-Fetal Medicine Fellowship Program

Click here for the first episode of RSV Roundtable.

Click here for the second episode of RSV Roundtable.

This series will release a new episode every Friday through January 5, 2024.

For a full list of already-published episodes, click here.

Thanks for watching RSV Roundtable.